Poly (ADP-ribose) polymerase inhibitors to treat diseases associated with cellular senescence
US5874444A · kind A · utility
49Cited by
9References
14Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Aug 27, 1996 |
| Grant date | Feb 23, 1999 |
| Priority date | — |
| Expiry date | Aug 27, 2016 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/473
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Inhibition of the enzyme poly (ADP-ribose) polymerase can delay the onset of senescence and inhibitors of the enzyme can be used to treat diseases caused or exacerbated by cellular senescence.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.